High Level Abstraction (HLA) | Report |
---|
(1) (health,diabetes,white) | 100.00 |
(2) (health,diabetes,risk) | 97.84 |
(3) (health,disease,risk) | 96.76 |
(4) (diabetes,risk,osteoarthritis) | 96.40 |
(5) (health,diabetes,osteoarthritis) | 94.96 |
(6) (health,disease,osteoarthritis) | 93.88 |
(7) (diabetes,mounjaro) | 93.17 |
(8) (health,diabetes,mounjaro) | 92.09 |
(9) (health,insurance,mounjaro) | 90.29 |
(10) (health,diabetes,los_angeles_unified_school_district) | 89.21 |
(11) (health,insurance,los_angeles_unified_school_district) | 87.41 |
(12) (health,diabetes,insurance) | 86.33 |
(13) (diabetes,white,glp-1) | 82.01 |
(14) (health,diabetes,glp-1) | 81.65 |
(15) (health,university,white) | 80.22 |
(16) (health,white) | 79.86 |
(17) (health,services) | 79.50 |
(18) (health,university,services) | 78.42 |
(19) (health,university,researcher) | 78.06 |
(20) (health,university,pharmaceutical) | 77.70 |
(21) (health,university,pennsylvania) | 77.34 |
(22) (health,university,jigchuan_guo) | 76.98 |
(23) (health,university,increased) | 76.62 |
(24) (health,insurance,prescribed) | 75.54 |
(25) (health,insurance,copay) | 75.18 |
(26) (health,household) | 73.74 |
(27) (health,disease,diabetes) | 73.38 |
(28) (diabetes,risk,chronic) | 71.94 |
(29) (health,disease,chronic) | 71.58 |
(30) (health,south_florida) | 70.50 |
(31) (diabetes,white,eberly) | 70.14 |
(32) (diabetes,glp-1,country) | 69.78 |
(33) (diabetes,white,country) | 67.27 |
(34) (diabetes,white,colleagues) | 66.91 |
(35) (diabetes,risk,food) | 66.55 |
(36) (diabetes,risk,drug_administration) | 66.19 |
(37) (diabetes,risk,disease) | 65.47 |
(38) (diabetes,risk,attacks) | 65.11 |
(39) (diabetes,ozempic) | 64.75 |
(40) (diabetes,glp-1,so-called) | 63.67 |
(41) (diabetes,so-called) | 62.95 |
(42) (diabetes,glp-1,receptor) | 62.23 |
(43) (diabetes,glp-1,day) | 61.15 |
(44) (diabetes,glp-1,agonist) | 59.35 |
(45) (loss,zepbound,drug,fda) | 58.27 |
(46) (diabetes,universal_studios) | 57.55 |
(47) (loss,drug,fda,wegovy) | 57.19 |
(48) (loss,drug,wegovy) | 52.52 |
(49) (loss,zepbound,drug,wegovy) | 49.64 |
(50) (loss,drug,diabetes) | 48.20 |
(51) (loss,drug,fda,diabetes) | 45.68 |
(52) (loss,zepbound,drug,diabetes) | 41.01 |
(53) (loss,drug,tag) | 38.49 |
(54) (loss,zepbound,drug,tag) | 35.61 |
(55) (loss,zepbound,tag) | 33.45 |
(56) (loss,drug,stop) | 33.09 |
(57) (loss,fda,mounjaro) | 25.18 |
(58) (loss,mounjaro) | 22.30 |
(59) (loss,zepbound,fda,mounjaro) | 21.22 |
(60) (loss,zepbound,mounjaro) | 18.35 |
(61) (loss,fda,wegovy) | 16.55 |
(62) (loss,wegovy) | 15.11 |
(63) (loss,zepbound,fda,wegovy) | 12.59 |
(64) (loss,zepbound,wegovy) | 11.15 |
(65) (loss,fda,peptide) | 10.07 |
(66) (loss,zepbound,fda,peptide) | 7.19 |
(67) (loss,zepbound,peptide) | 5.76 |
(68) (loss,fda,insulinotropic) | 5.40 |
(69) (loss,zepbound,fda,insulinotropic) | 3.96 |
(70) (loss,zepbound,insulinotropic) | 3.24 |
(71) (loss,fda,hormone) | 2.88 |
(72) (loss,zepbound,fda,hormone) | 1.80 |
(73) (loss,weight-related) | 1.44 |
(74) (loss,tag) | 1.08 |
(75) (loss,stop) | 0.36 |